Stocks and InvestingStocks and Investing
Fri, April 12, 2019
Thu, April 11, 2019
Wed, April 10, 2019
Tue, April 9, 2019
Mon, April 8, 2019
Fri, April 5, 2019
Thu, April 4, 2019
Wed, April 3, 2019
Tue, April 2, 2019
Mon, April 1, 2019
Fri, March 29, 2019

Alethia Young Maintained (ASND) at Buy with Decreased Target to $139 on, Mar 29th, 2019


Published on 2024-10-26 12:49:15 - WOPRAI, Alethia Young
  Print publication without navigation


Alethia Young of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $151 to $139 on, Mar 29th, 2019.

Alethia has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Alethia's Rating of Hold.



This is the rating of the analyst that currently disagrees with Alethia


  • Joseph Schwartz of "Leerink Swann" Upgraded from Hold to Buy and Increased Target to $90 on, Thursday, January 24th, 2019